Government Medical College

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Chronic kidney disease1 trial
• IgA nephropathy1 trial
• Multiple myeloma1 trial
• Obesity1 trial

Phase

• Phase 22 trials
• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Amgen1 trial
• Bayer1 trial
• Novartis Pharmaceuticals1 trial
• Sun Pharmaceutical Industries Limited1 trial

Running trials

• Recruiting

  Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

  NCT07282743· Phase 2· Sun Pharmaceutical Industries Limited· Source

  Contact: Head, Regulatory Affairs

• Active, not recruiting

  Atrasentan in Patients With IgA Nephropathy

  NCT04573478· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

  NCT05254002· Phase 2· Bayer· Source

• Completed

  Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

  NCT03934684· Phase 4· Amgen· Source